Lupenol
| Compound Structure: |
.png)
|
||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms: | (1R,3aR,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-ol; Lupeol; Fagarasterol; Clerodol; Monogynol B; farganasterol; Fagarsterol; Lupenol; T | ||||||||||||||||||||||||||||||||||||||||||
| Compound ID: | NMPC-1218 | ||||||||||||||||||||||||||||||||||||||||||
| PubChem ID: | |||||||||||||||||||||||||||||||||||||||||||
| Molecular Formula: | C30H50O | ||||||||||||||||||||||||||||||||||||||||||
| Canonical SMILES: | CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)O)C)C | ||||||||||||||||||||||||||||||||||||||||||
| InChIKey: | MQYXUWHLBZFQQO-QGTGJCAVSA-N | ||||||||||||||||||||||||||||||||||||||||||
| About the compound: | Lupeol is a pharmacologically active pentacyclictriterpenoid. It has several potential medicinal properties, like anticancer and anti-inflammatory activity. Lupeol is a pentacyclictriterpenoid that is lupane in which the hydrogen at the 3beta position is substituted by a hydroxy group. It occurs in the skin of lupin seeds, as well as in the latex of fig trees and of rubber plants. It is also found in many edible fruits and vegetables. It has a role as an anti-inflammatory drug and a plant metabolite. It is a secondary alcohol and a pentacyclictriterpenoid. It derives from a hydride of a lupane. GHS Hazard Statements H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] First Aid 1. Immediate First Aid: • Ensure decontamination is complete. • If the patient is not breathing, initiate artificial respiration using a device such as a demand valve resuscitator or bag-valve-mask. • Perform CPR if needed. • Flush contaminated eyes with water immediately. • Avoid inducing vomiting; if it occurs, position the patient to prevent aspiration. • Maintain the patient's body temperature and keep them calm. • Seek medical attention urgently. 2. Basic Treatment: • Establish and maintain a clear airway using devices if necessary. • Monitor for respiratory problems and assist with ventilations and administer high-flow oxygen via a nonrebreather mask. • Look out for and treat pulmonary edema and shock. • Be prepared to treat seizures. • For eye contamination, irrigate with saline during transport. • If ingestion occurs, rinse mouth and dilute the ingested material with water if safe to do so. • Cover skin burns with sterile dressings after decontamination. 3. Advanced Treatment: • Consider intubation for severe cases involving unconsciousness or severe respiratory distress. • Use positive-pressure ventilation if needed. • Employ medications for conditions such as pulmonary edema and severe bronchospasm. • Monitor and treat cardiac arrhythmias. • Administer intravenous fluids appropriately to manage fluid levels. • Treat seizures with appropriate medications and use specific agents to aid in eye irrigation. These steps are critical in managing cases of exposure to hazardous materials and should be performed by individuals trained in emergency care for such exposures. |
||||||||||||||||||||||||||||||||||||||||||
| Properties: |
Chemical and Physical Properties
Source: PubChem |
||||||||||||||||||||||||||||||||||||||||||
| Source Species: |
Vernonia cinerea |